What's Behind Ford Stock's New Sell Rating?
Jefferies downgraded Ford on concerns over earnings headwinds and "challenging decisions ahead." Here's what investors need to know.
Ford Motor (F) stock is moving lower Monday after financial services firm Jefferies downgraded the automaker to Underperform (equivalent to a Sell) from Hold and lowered its price target to $9 from $12.
Ford stock has disappointed investors so far in 2024 with a decline of more than 16% for the year to date. And Jefferies analyst Philippe Houchois sees further downside from here, citing an inventory overhang, an upcoming decision on its European presence and concerns over high warranty costs.
De-stocking has become an issue for Ford, Houchois says. While "the drift in inventory in recent months could help achieve the guided $8 billion in free cash flow guidance," it "also creates an overhang into 2025," he adds.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Regarding the company's "looming strategic decisions" on its European presence, Houchois questions Ford's ability to keep its operations going in the overseas market "given loss of scale in private vehicles," though exiting Europe "could hurt Pro's earnings."
Lastly, the analyst has "observed the gap between provisions made on repeated quality and warranty issues and the corresponding cash outflows" of approximately $8.5 billion since 2020, which equates to about $2 per share. Without a "dramatic improvement in quality," Houchois says these warranties will continue to be an overhang on Ford's net cash and balance sheet.
Ford stock is a Hold for most of Wall Street
The majority of Wall Street remains on the sidelines when it comes to the consumer discretionary stock. According to S&P Global Market Intelligence, the average analyst target price for F stock is $11.91, representing implied upside of about 19% to current levels. Meanwhile, the consensus recommendation is Hold.
Financial services firm Bernstein is one of those with a Market Perform rating (equivalent to a Hold) on the large-cap stock, along with an $11 price target.
"We like Ford's business for the high market share in U.S. trucks and improving battery electric vehicle (BEV) story," wrote Bernstein analyst Daniel Röska in a November 7 note. "But the upcoming quarters will likely see significant pricing headwinds in the U.S. market that neither Ford, nor its competitors will be able to escape."
Argus rates F a Buy
Not everyone is skeptical of Ford, though. Financial services firm Argus Research, for one, is bullish on the stock with a Buy rating and $13 price target.
"With the recently approved new labor agreement with the United Auto Workers in place and the restructured foreign operations now complete, (and showing a profit), we believe that the company's new heightened attention on reduction of costs, both structural and warranty, and its recently lowered capital expenditure program, will pave the way towards increased profitability in the next few years," said Argus Research analyst Bill Selesky in an October 29 note. "We believe that Ford shares offer value and remain attractively valued based on the company's global scale, brand reputation, and broad vehicle lineup, which continues to generate strong interest among consumers."
Related Content
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
-
15 Reasons You'll Regret an RV in Retirement
Making Your Money Last Here's why you might regret an RV in retirement. RV-savvy retirees talk about the downsides of spending retirement in a motorhome, travel trailer, fifth wheel or other recreational vehicle.
By Bob Niedt Published
-
Medicare’s 2025 Drug Negotiation List Includes Weight-loss Drugs Ozempic and Wegovy
The Centers for Medicare & Medicaid Services wants to lower the cost for 15 more drugs including Ozempic and Wegovy.
By Donna Fuscaldo Published
-
SLB Stock Jumps on Earnings, Dividend Hike and Buyback News
SLB stock is soaring Friday after the energy firm reported strong fourth-quarter earnings and unveiled several shareholder-friendly initiatives.
By Joey Solitro Published
-
Why J.B. Hunt Stock Is Sinking After Earnings
J.B. Hunt stock is notably lower Friday after the logistics company fell short of fourth-quarter earnings expectations. Here's what you need to know.
By Joey Solitro Published
-
Converting Retirement Savings to a Roth IRA? Don't Do This
You might want to convert all of your savings to a Roth in one go, but you could end up paying hundreds of thousands more in taxes than you have to.
By Joe F. Schmitz Jr., CFP®, ChFC® Published
-
What Is Your 'Enough Is Enough' Number for Retirement?
Chasing a 'magic number' for retirement can be anxiety-inducing. Instead, build your plans around a personal number that reflects your individual circumstances.
By Scott M. Dougan, RFC, Investment Adviser Published
-
California Wildfires and Insurance: Looking for Help
Los Angeles-based insurance expert Karl Susman shares the view from his agency’s office as all hands are on deck to help their policyholders.
By Karl Susman, CPCU, LUTCF, CIC, CSFP, CFS, CPIA, AAI-M, PLCS Published
-
Stock Market Today: Stocks Pause After a Big Rally
The Nasdaq continues to lag the S&P 500 and the Dow so far in 2025.
By David Dittman Published
-
Could ESG Funds be Removed from Your 401(k) Plan?
A pilot successfully sued American Airlines for including ESG factors in its 401(k) plan.
By Adam Shell Published
-
UnitedHealth Is the Worst Dow Jones Stock Thursday. Here's Why
UnitedHealth is putting pressure on the 30-stock index Thursday after the insurance giant reported a rare revenue miss. This is what you need to know.
By Joey Solitro Published